{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:35:16Z","timestamp":1787841316006,"version":"build-2784847793"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,13]],"date-time":"2017-05-13T00:00:00Z","timestamp":1494633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>A 52-year-old man with acute myeloid leukemia underwent allogeneic hematopoietic stem cell transplantation and developed extensive chronic graft-versus-host disease and myasthenia gravis (MG), which became involved with oculobulbar and proximal upper and lower limb weakness in 677 days. In the literature, we identified 24 cases where MG developed after allo-SCT. Graft-versus-host disease development and male recipients of female donors might be prone to the development of posttransplant MG (odds ratio, 3.75).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.hemonc.2017.04.001","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T13:35:48Z","timestamp":1495114548000},"page":"110-114","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["Myasthenia gravis after allogeneic bone marrow transplantation"],"prefix":"10.4103","volume":"12","author":[{"given":"Yutaka","family":"Tsutsumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kamiishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Teshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.hemonc.2017.04.001_b0005","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(85)91742-8","article-title":"Bone marrow grafting induces acetylcholine receptor antibody formation","volume":"1","author":"Smith","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.hemonc.2017.04.001_b0010","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/mus.21023","article-title":"Muscle-specific kinase (MuSK) antibody-associated myasthenia gravis after bone marrow transplantation","volume":"38","author":"Atassi","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.hemonc.2017.04.001_b0015","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/sj.bmt.1700759","article-title":"Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literature","volume":"19","author":"Mackey","year":"1997","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.hemonc.2017.04.001_b0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.bmt.1701297","article-title":"Myasthenia gravis without chronic GVHD after allogeneic bone marrow transplantation","volume":"2","author":"Baron","year":"1998","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.hemonc.2017.04.001_b0025","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/sj.bmt.1702067","article-title":"Myasthenia gravis after allogeneic bone marrow transplantation for lymphoblastic lymphoma","volume":"24","author":"Dowell","year":"1999","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.hemonc.2017.04.001_b0030","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1034\/j.1600-0609.2002.02789.x","article-title":"Myasthenia gravis after allogeneic bone marrow transplantation treated with mycophenolate mofetil monitored by peripheral blood OX40+CD4+T cells","volume":"69","author":"Kotani","year":"2002","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.hemonc.2017.04.001_b0035","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM198312223092508","article-title":"Myasthenia gravis after bone marrow transplantation. Evidence for a donor origin","volume":"309","author":"Smith","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hemonc.2017.04.001_b0040","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.bmt.1701575","article-title":"Myasthenia gravis and polymyositis as manifestation of chronic graft-versus-host disease","volume":"23","author":"Tse","year":"1999","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.hemonc.2017.04.001_b0045","first-page":"503","article-title":"A patient of chronic graft-versus-host disease presenting simultaneously with polymyositis and myasthenia gravis","volume":"41","author":"Yanagihara","year":"2001","journal-title":"Rinsho Shink"},{"key":"10.1016\/j.hemonc.2017.04.001_b0050","first-page":"649","article-title":"Myasthenia gravis after allogeneic bone marrow transplantation: a case report","volume":"15","author":"Zaja","year":"1995","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.hemonc.2017.04.001_b0055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0887-8994(94)00097-L","article-title":"Neuromuscular complications of bone marrow transplantation","volume":"12","author":"Adams","year":"1995","journal-title":"Pediat Neurol"},{"key":"10.1016\/j.hemonc.2017.04.001_b0060","first-page":"155","article-title":"Myasthenia gravis after allogeneic bone marrow transplantation","volume":"14","author":"Shimoda","year":"1994","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.hemonc.2017.04.001_b0065","first-page":"1390","article-title":"Immune complex glomerunephritis, myasthenia gravis and compensated hypothyroidism in a patient following allogeneic bone marrow transplantation","volume":"8","author":"Haslam","year":"1993","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.hemonc.2017.04.001_b0070","first-page":"78","article-title":"Myasthenia gravis after BMT: identification of patients at risk?","volume":"9","author":"Melms","year":"1992","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.hemonc.2017.04.001_b0075","first-page":"37","article-title":"Complicacoes pouco habituais da transplantacao de medulla ossea (TMO). Experiencia da Unidade de TMO do Instituo Portugus de Oncologia de Francisco Gentil, Centro de Lisboa","volume":"4","author":"Abecassis","year":"1991","journal-title":"Acta Med Portuguesa"},{"key":"10.1016\/j.hemonc.2017.04.001_b0080","first-page":"435","article-title":"Myasthenia gravis after allogeneic bone marrow transplantation: report of a new case and pathogenetic considerations","volume":"5","author":"Grau","year":"1990","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.hemonc.2017.04.001_b0085","first-page":"129","article-title":"Widespread pulmonary fibrosis as a major clinical manifestation of chronic graft-versus-host disease","volume":"4","author":"Atkinson","year":"1989","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.hemonc.2017.04.001_b0090","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1056\/NEJM198707163170314","article-title":"Antibodies against the acetylcholine receptor in hematologic disorders: implications for the development of myasthenia gravis after bone marrow grafting","volume":"317","author":"Lefvert","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hemonc.2017.04.001_b0095","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1212\/WNL.36.8.1087","article-title":"Myasthenia gravis after allogeneic bone marrow transplantation: relationship to chronic graft-versus-host disease","volume":"36","author":"Bolger","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.hemonc.2017.04.001_b0100","first-page":"221a","article-title":"Post bone marrow transplantation (BMT) myasthenia gravis: evidence for acetylcholine receptor (AChR) abnormality. Abstract","volume":"64","author":"Seely","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.hemonc.2017.04.001_b0105","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/pbc.24799","article-title":"Successful treatment of severe myasthenia gravis developed after allogeneic hematopoietic stem cell transplantation with plasma exchange and rituximab","volume":"61","author":"Unal","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.hemonc.2017.04.001_b0110","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.nmd.2013.11.005","article-title":"Muscle-specific kinase antibody associated myasthenia gravis after bone marrow transplantation","volume":"24","author":"Heidarzadeh","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.hemonc.2017.04.001_b0115","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.hemonc.2017.04.001_b0120","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000116395","article-title":"Auto antibody formation after bone marrow transplantation. Comparison between acetylcholine receptor antibodies and other autoantibodies and analysis of HLA and Gm markers","volume":"29","author":"Smith","year":"1989","journal-title":"Eur Neurol"},{"key":"10.1016\/j.hemonc.2017.04.001_b0125","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bbmt.2007.10.023","article-title":"Chronic graft-versus-host disease: how can we release Prometheus?","volume":"14","author":"Teshima","year":"2008","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.hemonc.2017.04.001_b0130","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1182\/blood-2003-03-0984","article-title":"Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors","volume":"103","author":"Mikos","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.hemonc.2017.04.001_b0135","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2004-09-3660","article-title":"Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission","volume":"105","author":"Mikos","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.hemonc.2017.04.001_b0140","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1084\/jem.20031560","article-title":"Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation","volume":"199","author":"Zorn","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.hemonc.2017.04.001_b0145","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1093\/brain\/awq245","article-title":"Neurological manifestation of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the consensus conference on clinical practice in chronic graft-versus-host disease","volume":"133","author":"Grauer","year":"2010","journal-title":"Brain"}],"container-title":["Hematology\/Oncology and Stem Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658387617300523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658387617300523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/02275670-201912020-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:49:28Z","timestamp":1787838568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/02275670-201912020-00006"}},"subtitle":["A case report and literature review"],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1016\/j.hemonc.2017.04.001","relation":{},"ISSN":["1658-3876"],"issn-type":[{"value":"1658-3876","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}